Product
Co-Trimoxazole
2 clinical trials
2 indications
Indication
Pneumocystis PneumoniaIndication
Spontaneous Bacterial PeritonitisClinical trial
A Phase 2, Proof-of-Concept, Multicentre, Open-Label, Randomised, Active-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Rezafungin Combined With 7 Days of Co-Trimoxazole Versus Co-Trimoxazole Monotherapy in HIV-Infected Adults With Pneumocystis Jirovecii PneumoniaStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in CirrhosisStatus: Active (not recruiting), Estimated PCD: 2025-10-01